# SODIUM NITROPRUSSIDE
> **ANDA209832** · Abbreviated New Drug Application (Generic) · Sponsor: AMPHASTAR PHARMS INC · Approved 2017-12-18
## Drug
- **FDA Application Number:** ANDA209832
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SODIUM NITROPRUSSIDE
- **Generic name:** Sodium Nitroprusside
- **Active ingredients:** SODIUM NITROPRUSSIDE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Discontinued
- **Sponsor:** AMPHASTAR PHARMS INC
- **First approval:** 2017-12-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209832)
---
*AI Analytics · CC0 1.0*